Ä¢¹½´«Ã½

Presentation

Insights into high-volume hemodiafiltration (HDF) therapy from a medical perspective, with a focus on:

• Differences between hemodialysis and high-volume HDF treatment modalities
• Overview of CONVINCE study
• FME experience with high-volume HDF globally
  Ìý

Franklin W. Maddux, MD,ÌýGlobal Chief Medical Officer and member of the Management Board

Presentation

Get insights on:

Ä¢¹½´«Ã½¦patient experience at home
Ä¢¹½´«Ã½¦new innovations in home dialysis
Ä¢¹½´«Ã½¦our path to 25% of home treatments in the U.S. by 2025

Frank Maddux, MD,ÌýGlobal Chief Medical Officer
Joe Turk,ÌýGlobal Head of Home

Presentation

Get insights on:
Ä¢¹½´«Ã½¦ our internal and external innovation pipeline,
Ä¢¹½´«Ã½¦ our R&D activities in the Renal Care Continuum and beyond,
Ä¢¹½´«Ã½¦ how innovation is linked to our strategy,
Ä¢¹½´«Ã½¦ and how it contributes to growth.

Dr. Olaf Schermeier,ÌýChief Executive Officer for Global Research and Development

Presentation

Get insights on:
Ä¢¹½´«Ã½¦ our latest product developments
Ä¢¹½´«Ã½¦ future prospects in our > 40 production sites
Ä¢¹½´«Ã½¦ why vertical integration matters
Ä¢¹½´«Ã½¦ how we ensure high quality standards

Rice Powell,ÌýChief Executive OfficerÌýand Chairman of the Management Board
Dr Katarzyna Mazur-Hofsäß,ÌýCEO EMEA
Kent Wanzek,ÌýCEOÌýGlobal Manufacturing, Quality and Supply